|
International Stem Cell Corporation (ISCO) |
|
International Stem Cell Corporation
ISCO's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into International Stem Cell growth rates, revenue grew
by 10.44 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1407
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.75 %
International Stem Cell net loss decreased from $0 millions, to $0 millions in III. Quarter 2024,
• More on ISCO's Growth
|
|
International Stem Cell realized a net loss in trailing twelve months.
International Stem Cell realized cash reduction of $ -0.02 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.09.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.
• More on ISCO's Valuation
|
|
|
|
|
International Stem Cell realized net loss in trailing twelve months.
International Stem Cell realized cash outflow of $ -0.02per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.09.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.
• More on ISCO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com